A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/formoterol Turbuhaler (160/4.5 μg/d) with Twice-daily Budesonide (400 μg/d) During the Step-down Period in Well-controlled Asthma [0.03%]
布地奈德/福莫特罗都宝(160/4.5μg/d，每日一次)与布地奈德气雾剂(400μg/d，每日二次)在哮喘降级治疗过程中疗效的对比研究：一项为期12周的随机、平行组、III期临床试验
Narongwit Nakwan,Thitima Perkleang,Thanida Tamsawai et al.
Narongwit Nakwan et al.
Objectives: Budesonide/formoterol fumarate (BUD/FF) is recommended in the stepwise management of uncontrolled asthma, but data on a once-daily dose of this medication in a step-down period are lacking. We aimed to compare...
The Role of Duration of Hyperbaric Oxygen Therapy on Lung Injury: An Experimental Study Lung Injury and Hyperbaric Oxygen Therapy [0.03%]
高压氧治疗时间对肺损伤影响的实验研究
Menduh Oruç,Bennur Esen,Maşuk Taylan et al.
Menduh Oruç et al.
Objectives: We aim to histopathologically analyze the effect of hyperbaric oxygen (HBO) therapy in the lung tissue. Material and methods: ...
Assessing the Prevalence and Incidence of Asthma and Chronic Obstructive Pulmonary Disease in the Eastern Mediterranean Region [0.03%]
评估东地中海区域哮喘和慢性阻塞性肺疾病的患病率和发病率
Mohammadreza Masjedi,Elaheh Ainy,Faried Zayeri et al.
Mohammadreza Masjedi et al.
Objectives: This study conducted in 2016 aimed to assess the prevalence and incidence of asthma and chronic obstructive pulmonary disease (COPD) in the Eastern Mediterranean Region (EMR). ...
Ufuk Çağırıcı,Oğuz Kılınç
Ufuk Çağırıcı